CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
Katz DA, Grimm DR, Cassar SC, Gentile MC, Ye X, Rieser MJ, Gordon EF, Polzin JE, Gustavson LE, Driscoll RM, O'dea RF, Williams LA, Bukofzer S.
Katz DA, et al. Among authors: gustavson le.
Clin Pharmacol Ther. 2004 Jun;75(6):516-28. doi: 10.1016/j.clpt.2004.01.013.
Clin Pharmacol Ther. 2004.
PMID: 15179406
Clinical Trial.